Advertisement
Advertisement
LBRX
L
LB Pharmaceuticals Inc Common Stock
30.73
USDSponsored
-0.04
-0.15%
Apr 24, 16:00 UTC -4
Closed
After-Market
30.73
0.00
0.00%
LBRX Earnings Reports
Positive Surprise Ratio
LBRX beat 1 of 1 last estimates.
100%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
LB Pharmaceuticals Inc Common Stock earnings per share and revenue
On Mar 26, 2026, LBRX reported earnings of -0.45 USD per share (EPS) for Q4 25, beating the estimate of -0.45 USD, resulting in a 1.42% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.81% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
KALA BIO, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.46
Actual
-$0.67
Surprise
+54.38%
Scilex Holding Company Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$0.47
Actual
-$2.21
Surprise
-360.99%
Lexaria Bioscience Corp. Common Stock
Report Date
Apr 13, 2026 For Q2 26
Estimate
-$0.09
Actual
-$0.06
Surprise
+38.08%
Quince Therapeutics, Inc. Common Stock
Report Date
Apr 10, 2026 For Q4 25
Estimate
-$1.92
Actual
-$7.10
Surprise
-268.68%
GeoVax Labs, Inc. New
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$6.29
Actual
$0.00
Surprise
+99.92%
FAQ
What were LB Pharmaceuticals Inc Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, LB Pharmaceuticals Inc Common Stock reported EPS of -$0.45, beating estimates by 1.42%, and revenue of $0.00, 0% as expectations.
How did the market react to LB Pharmaceuticals Inc Common Stock's Q4 2025 earnings?
The stock price moved down -2.81%, changed from $24.53 before the earnings release to $23.84 the day after.
When is LB Pharmaceuticals Inc Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for LB Pharmaceuticals Inc Common Stock's next earnings report?
Based on --
analysts, LB Pharmaceuticals Inc Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement